AI Outperforms Human Experts in Ovarian Cancer Detection
In a groundbreaking study led by researchers at the Karolinska Institutet in Sweden, artificial intelligence (AI) has demonstrated a remarkable ability to detect ovarian cancer, surpassing the accuracy of human doctors. This revelation, published in Nature Medicine, marks a significant advancement in the use of AI as a diagnostic tool.
The study involved training AI models on an extensive dataset of over 17,000 ultrasound images from 3,652 patients across 20 hospitals in eight countries. The AI achieved an accuracy rate of 86% in distinguishing between benign and malignant ovarian lesions. In comparison, human experts scored an accuracy of 82%, while less experienced examiners achieved 77%.
Study author Elisabeth Epstein, a professor at the Department of Clinical Science and Education at Karolinska Institutet, expressed her surprise at the AI’s performance, stating, “I was surprised that the AI models outperformed all 33 of the expert examiners.” This sentiment was echoed by other researchers who see AI as a promising tool to enhance diagnostic accuracy and efficiency.
Dr. Brian Slomovitz, director of gynecologic oncology at Mount Sinai Medical Center in Florida, described the early detection of ovarian cancer as the “holy grail” in reducing mortality rates. He noted that AI-driven support could improve the interpretation of ultrasound findings, reducing both false positives and negatives.
The potential of AI in medical diagnostics extends beyond just radiology. Factors such as menopausal status and blood test results could also be integrated into AI models, enhancing their diagnostic capability. However, experts like Dr. Harvey Castro caution that AI’s effectiveness hinges on access to diverse, high-quality data. He emphasized the need for further research to ensure AI’s adaptability to real-world clinical settings.
Epstein highlighted that while AI can significantly aid in diagnostics, it is not a replacement for human physicians. “It is still the physician who remains responsible for the patient’s diagnosis and treatment,” she stated.
The Karolinska Institutet team, in collaboration with the KTH Royal Institute of Technology, plans to initiate clinical studies at Stockholm South Hospital. This research was funded by several organizations, including the Swedish Research Council and the Swedish Cancer Society.
As AI continues to evolve, it holds the promise of transforming medical diagnostics, potentially leading to earlier cancer detection and improved patient outcomes. For more details, you can read the full article on WFIN.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Bluerate.ai—formerly MyMortgageRates—is stepping into 2025 with a mission to modernize a mortgage process that has barely changed in decades. Built by Zeitro, the platform equips both borrowers and loan officers with powerful AI tools, from online pre‑qualification and automated financial data extraction to instant guideline answers and scenario analysis. With more than 3,000 verified NMLS‑licensed loan officers and real‑time rate comparisons from major lenders, Bluerate.ai is quickly becoming a must‑know platform for mortgage and real estate professionals seeking speed, clarity, and a fully digital lending experience.
After the longest government shutdown in U.S. history, key federal housing programs such as FHA, VA, USDA, and NFIP are officially back in operation—offering long‑awaited relief to agents, lenders, and insurance professionals. But with a six‑week backlog slowing everything from loan guarantees to flood-insurance renewals, real estate pros should brace for delays and focus on resetting client expectations. A new federal spending deal restores funding through early 2026 and gives the market room to breathe, while NAR’s aggressive advocacy helped push the government toward reopening. Now, professionals who communicate clearly and stay on top of regulatory updates will be best positioned to guide clients through the temporary turbulence.
Commercial real estate is rapidly shifting toward a digital-first model, with platforms like Crexi leading the charge. By unifying property data, AI-driven insights, transparent bidding, and streamlined transaction tools, digital marketplaces are becoming essential to how modern CRE deals are sourced, analyzed, and closed. With more than 2 million monthly users and over $1 trillion in facilitated transactions, Crexi showcases how technology is reshaping the industry and giving real estate professionals a powerful competitive edge.
Europe’s biggest landlords—including Aroundtown, Vonovia, and top global investors—have teamed up to launch ATechX, a powerful new accelerator giving proptech startups something they rarely get: access to real buildings, real customers, and a clear path to scale across multiple countries. Designed to move founders beyond “pilot purgatory,” ATechX offers a true sandbox for innovation in Europe’s aging, regulation‑heavy property market, helping promising technology reach commercial traction faster than ever.
Mortgage rates are finally easing, inventory is climbing, and buyers are gaining leverage for the first time in years — yet sky‑high prices and economic jitters are keeping many on pause. With economists warning that inflation could push rates higher again, this fall may offer a rare window for well‑prepared buyers. Here’s what’s driving the shift, where opportunities are emerging, and how real estate professionals can stay ahead.
Griffin Funding has appointed John Jones as Senior Vice President of Growth and EOS Integrator, aiming to scale the company toward a $3 billion annual non-QM volume goal by 2030. After serving in fractional leadership roles since April 2025, Jones now steps in full‑time to lead organizational structure, efficiency, market expansion, and cross‑department alignment. Backed by strong liquidity and rising deal volume, Griffin Funding appears positioned for major industry impact in the years ahead.
